{"transactions":[{"id":778913,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:27:40.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on the first anniversary of May 12, 2026."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001193125-26-224148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526224148/ownership.xml","form_type":"4"}},{"id":1145297,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-16T20:05:22.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following May 15, 2025, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued on May 15, 2025 with an exercise price of $0.99, representing the closing stock price on May 15, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.99,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-25-073521","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017025073521/ownership.xml","form_type":"4"}},{"id":1465738,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-01T20:00:10.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following June 27, 2024, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024 with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024."}],"balance_after":125000,"derivative":{"exercise_price":1.05,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-24-079561","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017024079561/ownership.xml","form_type":"4"}},{"id":1902690,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-05T23:35:21.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months.  The options were issued at approximately 9:50 a.m. (ET) on May 4, 2023, with an exercise price of $0.662, representing the most recently reported closing stock price on May 3, 2023."}],"balance_after":125000,"derivative":{"exercise_price":0.662,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001437749-23-012869","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923012869/rdgdoc.xml","form_type":"4"}},{"id":2270263,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-05-16T22:24:38.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:30 a.m. (ET) on May 13, 2022, with an exercise price of $0.93, representing the most recently reported closing stock price on May 12, 2022."}],"balance_after":50000,"derivative":{"exercise_price":0.93,"expiration_date":"2032-05-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-22-012713","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774922012713/rdgdoc.xml","form_type":"4"}},{"id":2708035,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T20:18:40.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant."}],"balance_after":50000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-21-012677","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921012677/rdgdoc.xml","form_type":"4"}},{"id":3142659,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2020-05-19T18:05:51.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 15, 2020 with an exercise price of $1.70, representing the most recently reported closing stock price at the time of grant."}],"balance_after":45000,"derivative":{"exercise_price":1.7,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-20-011262","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774920011262/rdgdoc.xml","form_type":"4"}},{"id":3516845,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2019-05-22T00:07:00.000Z","date":"2019-05-17","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:00 a.m. (ET) on May 17, 2019 with an exercise price of $2.52, representing the most recently reported closing stock price at the time of grant."}],"balance_after":45000,"derivative":{"exercise_price":2.52,"expiration_date":"2029-05-17","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-19-010644","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774919010644/rdgdoc.xml","form_type":"4"}},{"id":3880462,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-29T20:02:51.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months."}],"balance_after":45000,"derivative":{"exercise_price":2.38,"expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001615774-18-005996","document":"s111130_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418005996/s111130_form4.xml","form_type":"4"}},{"id":3912510,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2018-05-31T19:29:07.000Z","date":"2018-05-30","kind":"purchase","acquired":true,"shares":2272,"price":1000,"value":2272000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares of Series B Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series B Convertible Preferred Stock and 284 Warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Securities are owned by Ensisheim Partners, LLC (\"Ensisheim\"). Shu-Chih Chen, Ph.D. and Steven C. Quay, M.D., Ph.D., share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Chen and Quay, and, as a result, Drs. Chen and Quay are deemed to be beneficial owners of the shares held by this entity."}],"balance_after":2272,"derivative":{"exercise_price":4.05,"exercise_date":"2018-05-30","expiration_date":"2022-05-30","underlying":"Common Stock","underlying_shares":2272},"source":{"system":"sec-edgar","filing":"0001615774-18-004659","document":"s110547_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418004659/s110547_form4.xml","form_type":"4"}},{"id":3912509,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-05-31T19:29:07.000Z","date":"2018-05-30","kind":"purchase","acquired":true,"shares":8,"price":1000,"value":8000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $3.52."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares of Series B Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series B Convertible Preferred Stock and 284 Warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series B Convertible Preferred Stock do not expire."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"No fractional shares will be issued upon conversion. At its election, the Company will either issue a cash adjustment or round up to the next whole share. The number reflected here assumes rounding up to the next whole share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Securities are owned by Ensisheim Partners, LLC (\"Ensisheim\"). Shu-Chih Chen, Ph.D. and Steven C. Quay, M.D., Ph.D., share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Chen and Quay, and, as a result, Drs. Chen and Quay are deemed to be beneficial owners of the shares held by this entity."}],"balance_after":8,"derivative":{"exercise_price":3.52,"exercise_date":"2018-05-30","underlying":"Common Stock","underlying_shares":2273},"source":{"system":"sec-edgar","filing":"0001615774-18-004659","document":"s110547_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418004659/s110547_form4.xml","form_type":"4"}},{"id":4302946,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47321,"kind":"person","name":"Chen Shu-Chih","position":1,"cik":"0001552127","reported_name":"Chen Shu-Chih","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-26T17:41:19.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":60202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months."}],"balance_after":80404,"derivative":{"exercise_price":0.47,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":60202},"source":{"system":"sec-edgar","filing":"0001615774-17-002737","document":"s106360_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577417002737/s106360_form4.xml","form_type":"4"}}]}